Literature DB >> 22160940

Bovine herpesvirus 1 protein bICP0 represses the transcription of bISG15 in fetal bovine lung cells.

Chang Liu1, Xiao-Hong Kong, Wen-Tao Qiao, Yun-Qi Geng.   

Abstract

The ubiquitin-like modifier bISG15 is an antiviral protein found in fetal bovine lung (FBL) cells. Bovine Herpesvirus 1(BHV-1), which is a viral pathogen of cattle, can infect FBL cells and induce cytopathic effects. Real-time PCR assays showed that BHV-1's infection could repress the basal or inducible transcription of bISG15 in FBL cells. It demonstrates that this repression effect depends on BHV-1 viral infection and new protein synthesis. Our previous work showed that bIRF-3 was the key factor in the stimulation of bISG15 in FBL cells, so the effect of BHV-1 viral protein on bIRF-3 activating the promoter of bISG15 was confirmed. The luciferase assay showed the BHV-1 viral protein bICP0 inhibited the activation of bISG15 promoter stimulated by bIRF-3. Taken together, our work suggested that BHV-1 had some molecular mechanism to resist the cellular bISG15's antiviral functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160940      PMCID: PMC8222493          DOI: 10.1007/s12250-011-3213-x

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  The Interferon Stimulated Genes (ISG) 17 and Mx have different temporal and spatial expression in the ovine uterus suggesting more complex regulation of the Mx gene.

Authors:  G A Johnson; M M Joyce; S J Yankey; T R Hansen; T L Ott
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

3.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.

Authors:  Atsushi Okumura; Gengshi Lu; Ian Pitha-Rowe; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-24       Impact factor: 11.205

4.  ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.

Authors:  G Lu; J T Reinert; I Pitha-Rowe; A Okumura; M Kellum; K P Knobeloch; B Hassel; P M Pitha
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-05-15       Impact factor: 1.770

5.  The Bovine herpesvirus 1 gene encoding infected cell protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral genes.

Authors:  Gail Henderson; Yange Zhang; Clinton Jones
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

Review 6.  Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency.

Authors:  C Jones; V Geiser; G Henderson; Y Jiang; F Meyer; S Perez; Y Zhang
Journal:  Vet Microbiol       Date:  2005-12-13       Impact factor: 3.293

7.  The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1.

Authors:  T P Moynihan; H C Ardley; U Nuber; S A Rose; P F Jones; A F Markham; M Scheffner; P A Robinson
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

8.  ISG15 expression in response to double-stranded RNA or LPS in cultured Fetal bovine lung (FBL) cells.

Authors:  C Liu; R Chang; X Yao; W T Qiao; Y Q Geng
Journal:  Vet Res Commun       Date:  2009-04-15       Impact factor: 2.459

9.  ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity.

Authors:  Atsushi Okumura; Paula M Pitha; Ronald N Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

10.  Acute non-cytopathic bovine viral diarrhea virus infection induces pronounced type I interferon response in pregnant cows and fetuses.

Authors:  Natalia P Smirnova; Helle Bielefeldt-Ohmann; Hana Van Campen; Kathleen J Austin; Hyungchul Han; Donald L Montgomery; Megan L Shoemaker; Alberto L van Olphen; Thomas R Hansen
Journal:  Virus Res       Date:  2007-11-28       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.